This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Rigel Pharmaceuticals, Incorporated. Active years: 2007-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2021
Title: Innovations by Inventor Nan Lin
Introduction
Nan Lin is a prominent inventor based in Foster City, CA (US). He has made significant contributions to the field of pharmaceuticals and bioinformatics. With a total of 2 patents, his work focuses on advancing medical treatments and biological data analysis.
Latest Patents
One of Nan Lin's latest patents is for Direct AMPK activators. This invention discloses benzimidazole compounds, along with pharmaceutical compositions and methods of use. The patent describes a compound that activates AMPK, which can be utilized to treat diseases by activating the AMPK pathway. Another notable patent is for Multidimensional biodata integration and relationship inference. This invention provides an advanced platform for analyzing biological data, emphasizing pathway mapping and relationship inference based on data from multiple diverse sources. The platform integrates data from various sources, connecting related genes and proteins while inferring biological functions in the context of global cellular processes.
Career Highlights
Nan Lin is currently associated with Rigel Pharmaceuticals, Incorporated, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing new therapeutic strategies and enhancing our understanding of biological systems.
Collaborations
Some of his notable coworkers include Kunbin Qu and Yanmei Lu, who contribute to the collaborative efforts in research and development at Rigel Pharmaceuticals.
Conclusion
Nan Lin's contributions to the fields of pharmaceuticals and bioinformatics highlight his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to improving health outcomes through scientific discovery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
